SurgiLogix
Supplier of human tissue allografts (amniotic membrane-derived products and demineralized bone matrix). Operations include donor procurement and medical screening, tissue processing in an AATB-accredited facility with communicable-disease testing performed by FDA-registered/CLIA laboratories, sterilization and preservation, product release testing per USP guidance, product distribution through independent distributors, and clinician education and referral support.
Industries
Nr. of Employees
small (1-50)
SurgiLogix
11503 NW Military Hwy, Suite 307 San Antonio, TX 78231
Products
Amniotic membrane allografts (amnion-derived membrane patches)
Minimally manipulated placental-derived membrane allografts intended to cover, protect and support damaged tissue and wounds; applicable for suturing, adhesion or placement in surgical and office settings.
Demineralized bone matrix allografts (DBM)
Allograft bone material demineralized to expose bone morphogenetic proteins and provided in putty, strip, cube or fibrous formats to fill bone voids or defects.
Amniotic membrane allografts (amnion-derived membrane patches)
Minimally manipulated placental-derived membrane allografts intended to cover, protect and support damaged tissue and wounds; applicable for suturing, adhesion or placement in surgical and office settings.
Demineralized bone matrix allografts (DBM)
Allograft bone material demineralized to expose bone morphogenetic proteins and provided in putty, strip, cube or fibrous formats to fill bone voids or defects.
Services
Onboarding and ongoing commercial support for independent distributors, including marketing materials, training, contracting assistance and order support.
Curated educational materials (research reports, videos, brochures, FAQs) for clinicians and patients on applications and safety of amniotic tissue and DBM allografts.
Service to match patients with physicians who use the company's allografts and to aid clinicians in locating product-using peers.
Onboarding and ongoing commercial support for independent distributors, including marketing materials, training, contracting assistance and order support.
Curated educational materials (research reports, videos, brochures, FAQs) for clinicians and patients on applications and safety of amniotic tissue and DBM allografts.
Service to match patients with physicians who use the company's allografts and to aid clinicians in locating product-using peers.
Expertise Areas
- Human tissue allograft manufacturing and supply
- Amniotic membrane-derived allografts
- Demineralized bone matrix (DBM) products and formats
- Donor procurement and infectious-disease screening
Key Technologies
- Amniotic membrane processing techniques
- Demineralized bone matrix processing
- Lyophilization (freeze-drying) of tissue grafts
- Gamma irradiation sterilization
News & Updates
Summary of a program to standardize processes and materials for regenerative-medicine manufacturing led by an academic regenerative-medicine institute and partners.
Overview of FDA Regenerative Medicine Advanced Therapy (RMAT) designation and its potential to provide earlier interactions and expedited review pathways for eligible regenerative-medicine products.
Summary of clinical and preclinical literature reviewing uses of amniotic tissue in orthopedic applications and the current evidence base.
Summary of a prospective randomized controlled trial evaluating freeze-dried amnion grafts to prevent intrauterine adhesion reformation after hysteroscopic adhesiolysis (study citation included).
Announcement describing a 100% demineralized cortical bone fibrous DBM format intended to provide a malleable, porous scaffold for bone repair applications.
Site announcement of an upcoming amniotic-tissue allograft intended for homologous use to supplement tissue for protection, cushioning and lubrication.
Summary of a program to standardize processes and materials for regenerative-medicine manufacturing led by an academic regenerative-medicine institute and partners.
Overview of FDA Regenerative Medicine Advanced Therapy (RMAT) designation and its potential to provide earlier interactions and expedited review pathways for eligible regenerative-medicine products.
Summary of clinical and preclinical literature reviewing uses of amniotic tissue in orthopedic applications and the current evidence base.
Summary of a prospective randomized controlled trial evaluating freeze-dried amnion grafts to prevent intrauterine adhesion reformation after hysteroscopic adhesiolysis (study citation included).
Announcement describing a 100% demineralized cortical bone fibrous DBM format intended to provide a malleable, porous scaffold for bone repair applications.
Site announcement of an upcoming amniotic-tissue allograft intended for homologous use to supplement tissue for protection, cushioning and lubrication.